last update: November 14, 2025
Bupropion is an antidepressant most commonly prescribed for major depressive disorder (MDD) and seasonal affective disorder (SAD). In clinical practice, it is also used to support smoking cessation under the brand name Zyban, and it may be considered off-label in select cases as an adjunct to other antidepressants, to mitigate SSRI-related sexual dysfunction or fatigue, or to address attention symptoms when clinically appropriate. Because it acts differently than selective serotonin reuptake inhibitors (SSRIs), bupropion can be a valuable option for people who have not responded well to other antidepressants or who prefer a medication with a lower likelihood of sexual side effects or weight gain.
By targeting norepinephrine and dopamine pathways in the brain, bupropion can help improve energy, motivation, concentration, and mood. It is not a sedating antidepressant; in fact, it can be activating for some people, which is helpful for daytime functioning but may cause insomnia if taken too close to bedtime.
Bupropion is a norepinephrine-dopamine reuptake inhibitor (NDRI). It increases the availability of norepinephrine and dopamine by inhibiting their reuptake into neurons. These neurotransmitters are central to mood regulation, drive, and cognitive function. Unlike SSRIs and SNRIs, bupropion has minimal direct serotonergic activity, which explains its different side effect profile. In smoking cessation, bupropion helps reduce nicotine cravings and withdrawal symptoms by modulating dopaminergic reward circuits.
Because of its pharmacology, bupropion tends to be weight-neutral and is less likely than many antidepressants to cause sexual dysfunction. However, it can increase blood pressure and lowers the seizure threshold in a dose-dependent manner. These characteristics shape who is a good candidate for treatment and how the medication is prescribed.
Use bupropion exactly as directed by your clinician. It is available in immediate-release (IR), sustained-release (SR), and extended-release (XL) formulations. Do not crush, split, or chew SR or XL tablets. Swallow them whole to preserve their release characteristics and reduce side effect risks.
Special dosing considerations are important for individuals with kidney or liver impairment, older adults, and people using interacting medications. In these cases, lower starting doses, slower titration, or lower maximum doses may be recommended.
Store bupropion at room temperature between 59 and 77 degrees F (15 and 25 degrees C) in a tightly closed, light-resistant container. Keep it away from moisture, heat, and direct light. Do not store it in the bathroom. Keep out of reach of children and pets. Proper storage helps maintain potency and safety, especially for extended-release tablets.
Do not use bupropion if any of the following apply:
Use bupropion with caution and only with clinician guidance if you have any of the conditions below:
Bupropion participates in several clinically significant interactions. Always provide a complete list of prescriptions, nonprescription drugs, supplements, nicotine products, and recreational substances to your healthcare team.
This list is not exhaustive. If you start, stop, or change the dose of any medication, check with your clinician for interaction risks and needed monitoring.
Many people tolerate bupropion well, but side effects can occur. Some are transient and improve as your body adjusts; report persistent or severe symptoms to your clinician.
Call emergency services for symptoms of a life-threatening reaction, such as trouble breathing, severe chest pain, or seizures. Contact your clinician promptly for new or worsening mood symptoms, including suicidal thoughts.
Pregnancy: Decision-making in pregnancy balances the risks of untreated depression against the potential risks of medication. Available data do not suggest a major increase in congenital malformation risk with bupropion, but findings are not definitive. If you become pregnant while taking bupropion, inform your clinician promptly to discuss whether to continue, adjust, or switch therapy. Do not stop abruptly without medical advice.
Breastfeeding: Bupropion and its active metabolites are present in breast milk. Most infants exposed via milk do well, but rare irritability or feeding issues have been reported. If breastfeeding while taking bupropion, your pediatrician may recommend monitoring for sleep or feeding changes in the infant.
Liver or kidney impairment: Reduced clearance can increase drug exposure. Lower starting doses and slower titration are often used, with careful monitoring for side effects.
Cardiovascular disease: Monitor blood pressure and heart rate. Discuss risks if you have a history of arrhythmia or uncontrolled hypertension.
Neurologic conditions: A history of seizure, significant head injury, or a brain tumor generally precludes use. If you have risk factors for seizures, your clinician may recommend a different antidepressant or a lower maximum dose with enhanced monitoring.
Bupropion differs from SSRIs and SNRIs in its mechanism and adverse effect profile. It tends to be less sedating and less likely to cause weight gain or sexual dysfunction. Conversely, it can be more activating and may increase blood pressure or anxiety in some people. Those with prominent fatigue, low energy, or concentration difficulties often do well on bupropion; those with severe insomnia or prominent anxiety may require careful dose timing, dose reduction, or a different agent. Combination strategies (for example, bupropion added to an SSRI) are common when partial response occurs, but they require oversight due to interaction potential.
Bupropion is widely available as a lower-cost generic in IR, SR, and XL forms. Prices vary by dose and pharmacy. Many patients lower out-of-pocket costs by using generic XL once daily or SR twice daily formulations, depending on insurance coverage and clinical fit. Patient assistance programs, discount cards, and pharmacy comparison tools can reduce costs substantially.
In the United States, Canada, and the United Kingdom, bupropion is a prescription-only medicine. Safe access means obtaining it from a licensed prescriber and a licensed pharmacy. Be cautious with online offers that advertise prescription medications at unusually low prices, offer shipment without a valid prescription, or do not require a legitimate health assessment. Such sources may be unsafe or unlawful and can expose you to counterfeit or substandard medicines.
In the United States, bupropion (including Wellbutrin, Wellbutrin SR, Wellbutrin XL, Aplenzin, and Zyban) is an FDA-approved, prescription-only medication. Federal and state laws require a valid prescription from a licensed clinician for dispensing. This requirement helps ensure that people receive the right dose and formulation, are screened for seizure risk and other contraindications, and are monitored for side effects and treatment response.
Legitimate access options include in-person visits with primary care clinicians, psychiatrists, and addiction specialists, as well as via licensed telehealth services that conduct proper evaluations. Pharmacies must be state-licensed to dispense prescription medications, including mail-order and online pharmacies. Consumers should be wary of any site offering bupropion without a prescription, as such offers may be unlawful and carry significant safety risks.
HealthSouth Rehabilitation Hospital of Petersburg supports lawful, patient-centered access to care by coordinating services with licensed clinicians and accredited pharmacies. Through structured clinical evaluation, eligible patients may receive a prescription when medically appropriate, along with guidance on dosing, safety, and follow-up. This approach preserves convenience while adhering to U.S. regulations designed to protect patients from unsafe or counterfeit products.
Bupropion is an antidepressant that inhibits the reuptake of norepinephrine and dopamine (an NDRI), helping improve mood, energy, and focus without significant serotonin effects.
It is approved for major depressive disorder, seasonal affective disorder, and smoking cessation; it’s also used off-label in some cases for ADHD and antidepressant-induced sexual dysfunction.
Common brands include Wellbutrin (IR, SR, XL) and Zyban for smoking cessation; Aplenzin is a bupropion hydrobromide formulation with different tablet strengths.
Some people notice more energy or motivation in 1–2 weeks, but full mood benefits often take 4–6 weeks; for smoking cessation, start 1 week before your quit date.
SR is typically taken twice daily at least 8 hours apart, while XL is taken once each morning; take consistently and avoid evening doses to reduce insomnia.
For depression, 150–300 mg/day XL or 150 mg twice daily SR is common, with a maximum of 450 mg/day (HCl) due to seizure risk; dosing is individualized by your clinician.
Insomnia, dry mouth, headache, nausea, anxiety, tremor, and decreased appetite are most common; blood pressure may rise slightly in some people.
Seizures (rare, dose-related), severe anxiety or agitation, hypertensive reactions, allergic rash, eye pain/blurred vision (angle-closure glaucoma), and mood changes like mania require urgent medical attention.
It is contraindicated with a seizure disorder, current or prior bulimia or anorexia nervosa, abrupt alcohol/benzodiazepine/sedative withdrawal, recent MAOI use, or known hypersensitivity.
Bupropion is generally weight-neutral or associated with modest weight loss, especially compared with many SSRIs and mirtazapine.
It has a low risk of sexual side effects and may improve SSRI-induced sexual dysfunction in some patients.
Yes, its activating profile can worsen anxiety or cause insomnia, especially at the start; morning dosing, slower titration, and avoiding caffeine later in the day can help.
Avoid MAOIs, linezolid, and IV methylene blue; bupropion is a strong CYP2D6 inhibitor and can raise levels of drugs like metoprolol, TCAs, many antipsychotics, and may reduce tamoxifen effectiveness; combining with other seizure-threshold–lowering drugs (tramadol, theophylline, stimulants) increases risk.
No; SR and XL tablets must be swallowed whole to avoid dose-dumping and seizure risk; ask your clinician if you need a different formulation.
Take it when remembered unless it’s close to the next dose; never double up or take extra doses to catch up.
No; bupropion is not a controlled substance and is not known to cause dependence, though it should be tapered if used long-term to reduce discontinuation symptoms.
It’s best to avoid or strictly limit alcohol; combining increases seizure risk and can worsen mood or sleep.
Do not take extra doses; if you’ve binged or are withdrawing from alcohol, contact your clinician promptly because seizure risk is higher—skipping a dose may be advised.
Discuss with your obstetric provider; data do not show a major increase in birth defects, but risks and benefits should be individualized based on depression severity and alternatives.
Small amounts pass into breast milk; many infants tolerate it, but monitor for irritability, poor feeding, or seizures, and review risks/benefits with your pediatrician and prescriber.
Do not stop abruptly unless instructed; most patients continue through surgery, but always inform your surgical and anesthesia teams due to seizure-threshold and interaction considerations.
Generally no; seizure risk is increased with prior seizures, significant head trauma, brain tumors, or concurrent seizure-threshold–lowering drugs—use alternatives.
No; current or past bulimia or anorexia nervosa is a contraindication due to a substantially increased seizure risk.
Until you know how you respond, use caution; if you feel jittery, dizzy, or sleepless, avoid driving or operating machinery and speak with your clinician.
Both are effective; sertraline (an SSRI) often works better for prominent anxiety or OCD but has higher rates of sexual dysfunction and GI upset, while bupropion is more activating and weight-neutral.
Bupropion tends to boost energy and motivation with fewer sexual side effects; fluoxetine can also be activating but has more serotonergic side effects and a longer half-life.
Bupropion has a lower risk of sexual dysfunction; escitalopram is very well tolerated overall but commonly causes decreased libido and delayed orgasm.
Venlafaxine often outperforms bupropion for generalized anxiety and panic; bupropion may exacerbate anxiety early on but causes fewer sexual side effects and less sweating.
Duloxetine treats depression and neuropathic pain/fibromyalgia; bupropion does not target pain but is less likely to cause sexual dysfunction or sweating and may be more energizing.
Mirtazapine improves sleep and appetite and often causes weight gain; bupropion can cause insomnia and is weight-neutral or modestly weight-reducing.
Vortioxetine may offer pro-cognitive benefits and has relatively favorable sexual side effect rates; bupropion improves attention and energy via dopamine/norepinephrine but lacks serotonergic cognitive data.
Paroxetine has higher risks of weight gain, sexual dysfunction, anticholinergic effects, and difficult discontinuation; bupropion avoids most of these but may worsen anxiety early.
Both treat depression; TCAs like nortriptyline can be very effective but carry anticholinergic effects, orthostasis, and cardiac risks, whereas bupropion is safer in overdose and better tolerated.
Trazodone is more sedating and commonly used for sleep; bupropion is activating and may worsen insomnia but treats depression and aids smoking cessation.
Desvenlafaxine may raise blood pressure and has notable discontinuation symptoms; bupropion can also elevate BP but typically less so and has fewer sexual side effects.
XL is once daily, SR is twice daily, and IR is usually three times daily; XL/SR provide steadier levels and lower peak-related side effects—never crush or split any formulation.
You may also like to read "First Week of Therapy with Bupropion" Review.